Find A PhysicianHome  |  Library  |  myDownstate  |  Newsroom  |  A-Z Guide  |  E-mail  |  Contact Us  |  Directions

SUNY Downstate Health Sciences University

Office of Research Administration

Find COVID-19 Funding Opportunities

COVID-19 Funding Opportunities by Institute

The following opportunities represent both federal and non-federal funding opportunities. The federal opportunities are also posted on the Grants.gov, NIH Guide for Grants and Contracts, and NSF.Gov.

Investigators should check eligibility and obtain any necessary approvals before applying.

Notice of Special Interest (NOSI) applies to Administrative Supplements and Revision Supplements only for Coronavirus.

Revised 5/15/2020

 

23 and Me 

The 23andMe Research Innovation Collaborations Program pairs up academic researchers with 23andMe scientists to perform analyses. Through this program, academic researchers can access de-identified, aggregated data from the 23andMe Research Cohort. The 23andMe database is a rich resource, with genotypic and phenotypic information from more than 5 million of our customers, 80 percent of whom consent to participate in 23andMe Research. By consenting to participate, our customers agree to make their de-identified genetic data available for study in aggregate and take part in online research under a protocol approved by an external institutional review board (IRB). These research participants also answer online survey questions on a variety of topics, and to date have contributed over 2 billion phenotypic data points.

23andMe Research; Deadline: Rolling

 

Amazon Web (AWS) 

The AWS Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. Although vaccine and treatment development research is generally funded by private foundations and government agencies, fast and reliable diagnostic techniques are slow to be developed. Accurate testing and diagnosis at point-of-care or regional locations for patients with COVID-19 is critical to early intervention and treatment. AWS is offering technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies.

AWS Diagnostic Development Initiative (DDI); Deadline: June 30, 2020

 

AHRQ

Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19

PA20-071; Deadline: Forecasted

Novel, High Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19

RFA-HS-20-003; Deadline: LOI June 1, 2020; Application June 15, 2020 

 

Argonne National Laboratory

Expedited, Rapid Access Call for COVID-19 Research 

Deadline: July 2, 2020

 

Coalition for Economic Preparedness Innovations (CEPI) 

Proposals to accelerate the development of safe and effective vaccines in 12-18 months or less.

COVID-19_CFP_2C; Deadline: June 30, 2020 Deadline Updated

 

DHHS

Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)

PA-19-237; Deadline: June 16, 2020

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

PAR-20-155; Deadline: Standard Dates apply

Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

BARDABAA; Deadline: White Paper submission deadlines are at the end of every month. The final White Paper submission deadline is October 31, 2020; Applications due 10/31/2020.

Bench Testing Therapeutic/Indication Pairing Strategies;. This Funding Opportunity Announcement (FOA) invites applications for support of pre-clinical studies to repurpose existing experimental or FDA approved drugs or biologics (existing therapeutics) that have already begun or completed at least a Phase l trial. The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. 

PAR-17-465; Deadline: June 26, 2020; October 30, 2020

 

DOD

CDMRP PRMRP Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health

W81XWH-20-PRMRP-IIRA-COV; Deadline: June 12, 2020

CDMRP PRMRP Technology/Therapeutic Development Award for Emerging Viral Diseases and Respiratory Health

W81XWH-20-PRMRP-TTDA-COV; Deadline: June 12, 2020

CDMRP PRMRP Clinical Trial Award for Emerging Viral Diseases and Respiratory Health

W81XWH-20-PRMRP-CTA-COV; Deadline: June 22, 2020

 

Emergency Medicine Foundation 

The Emergency Medicine Foundation is awarding funding of up to $100,000 in new research grants on emergency medicine areas related to COVID-19.

Request for Proposal; Grant requests can range from $10,000 to $50,000; Deadline: June 5, 2020

 

Facebook

Economic Impact of Digital Technologies Request for Proposals; Deadline: May 20, 2020

Facebook is issuing a call for academic research proposals as part of its pledge to contribute $1 million to research that addresses the economic impact of digital technologies, including new tools that enable commercial opportunities.

 

IBM; IBM X Prize 

Build a coding solution that can provide immediate crisis communication, enhanced remote education, or stronger community cooperation.

2020 COVID-19 Call for Code Global Challenge; Deadline: 7/31/2020

 

Indo-US Science & Technology Forum (IUSSTF) NEW

Each proposals must include one institution from India and one from the U.S.

Call for Proposals; Deadline: 5/15/2020

 

InnoCentive

Ideation Challenge: What Should We Know to Better Treat Coronavirus?  Deadline: May 24, 2020

This Challenge is asking InnoCentive Solvers to formulate well-defined problems aimed at advancing our knowledge about Coronavirus. One could think of this as what might we have known that would have allowed us to respond more effectively against COVID-19.

Challenge: Looking for a film to provent infection

The Challenge is looking for a thin film that, when applied to hands and other open parts of the human body, would prevent people from being infected with the COVID-19 virus.

Anti-COVID-19 Infection Protective Film; Deadline: June 15, 2020

Ideation Challenge: Gamification to Prevent the Spread of Coronavirus NEW

Gamification has been long recognized as a powerful approach to changing social behavior, including health related behavior. The objective of this challenge is to apply gamification to changing people's social behavior to prevent the spread of Coronavirus and other infections.

Gamification to Prevent the Spread of Coronavirus; Deadline: June 12, 2020    

 

Institute for Global Health 

The Institute for Global Health is pleased to share this call for applications to supporting member faculty COVID-19 projects, including, but not limited to, events, education, community engagement, or implementation projects. These funds are not intended to support research projects. Those interested in research awards should apply for COVID-19 Research Catalyzer Funding for Faculty.

COVID-19 Global Health Projects; Deadline: Immediately and up to June 1, 2020

 

Internet Society Foundation 

Our Emergency Response Programme will provide funding to organizations working on projects that utilize the Internet to improve lives during or in response to an emergency situation. In 2020, the Foundation’s focus will be on projects that respond to the COVID-19 pandemic, both during the immediate period of the crisis but also looking ahead at responses to the inevitable “second wave” later this year/into 2021. 

2020 Focus: Coronavirus and COVID-19; Deadline: 5/17/2020

 

Jacob and Valeria Langeloth Foundation NEW

The CRRF was put in place to enable Langeloth to address organizations’ urgent and critical needs that have arisen due to the COVID-19 global pandemic.

COVID-19 Rapid Response Fund; Deadline: Rolling

 

Kaggle

COVID-19 Open Research Dataset Challenge (CORD-19)

 

Merck KGaA (Germany) 

The threat from newly emerging viral infections is one of the top global challenges for humanity. The recent COVID-19 pandemic shows that pandemic preparedness and having the right products and technology to fight infectious diseases with epidemic and pandemic potential is of utmost importance. It is required to act quickly to limit further substantial damages to society, economy and ecology.

Research Grant for Pandemic Preparedness; Deadline: Rolling

 

Mozilla/Moss

COVID-19 Solutions Funds; Deadline: Rolling

 

NIH

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NIH)

NOT-HL-20-757; Deadline: Applications accepted on a rolling basis through October 6, 2020

Emergency Awards: RADx_UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) NEW

RFA-OD-20-013; Deadline: LOI - July 8, 2020; Application deadline - August 7, 2020

 

NCCIH

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) (NCCIH, NIA, NIAAA)

NOT-AT-20-011; Deadline: Applications accepted on a rolling basis through October 6, 2020

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI)

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

 

NCI

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (NIMHD, NIA, NIDA, NCI)

PA-20-172; Deadline: Letter of Intent - 9/4/2020; Application - 10/5/2020

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI)

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

 

NHGRI

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NHGRI)

NOT-HG-20-030; Deadline: Applications accepted on a rolling basis through May 15, 2020

 

NHLBI

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI)

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

 

NIA

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (NIMHD, NIA, NIDA, NCI)

PA-20-172; Deadline: Letter of Intent - 9/4/2020; Application - 10/5/2020

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) (NCCIH, NIA, NIAAA)

NOT-AT-20-011; Deadline: Applications accepted on a rolling basis through October 6, 2020

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NIA, NIMH)

NOT-AG-20-022; Deadline: Applications accepted on a rolling basis through May 1, 2021

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI)

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

 

NIAAA

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) (NCCIH, NIA, NIAAA)

NOT-AT-20-011; Deadline: Applications accepted on a rolling basis through October 6, 2020

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI)

NOT-OD-20-097; Deadline: Applications will be accepted on a rolling basis, beginning on 04/30/2020 NEW

 

NIAID

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NIAID)

NOT-AI-20-034; Deadline: Applications accepted on a rolling basis through March 25, 2021

Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NIAID)

NOT-AI-20-031; Deadline: Applications accepted on a rolling basis through April 5, 2021

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) 

PAR-20-178; R01 - Deadline: Applications accepted on a rolling basis through April 5, 2021 NEW

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) 

PAR-20-177; R21 - Deadline: Applications accepted on a rolling basis through April 5, 2021 NEW

 

NIBIB

NEW: Fast-Track Program for COVID-19 Test Development and Distribution; Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing. NIBIB is providing substantial support to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. NIBIB will support the full range of product development including commercialization and product distribution.

Rapid Acceleration of Diagnostics (RADx); Deadline: Rolling

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NIBIB)

NOT-EB-20-008; Deadline: Applications accepted on a rolling basis through November 20, 2020

 

NIDA

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (NIMHD, NIA, NIDA, NCI)

PA-20-172; Deadline: Letter of Intent - 9/4/2020; Application - 10/5/2020

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NIDA)

NOT-DA-20-047; Deadline: Applications accepted on a rolling basis through March 31, 2021

 

NIDDK

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI)

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

 

NIEHS

Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NIEHS)

NOT-ES-20-015; Deadline: Applications accepted on a rolling basis through May 3, 2021

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI)

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NIEHS)

NOT-ES-20-020; Deadline: Applications accepted from May 1, 2020 through May 3, 2021

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI)

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

 

NIGMS

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NIGMS)

NOT-GM-20-025; Deadline: Applications accepted on a rolling basis through February 5, 2021

NEW  Notice of Special Interest (NOSI): Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Need for Documenting 2019 Novel Coronavirus Disease (COVID-19) -Related Patient Outcomes

NOT-GM-20-033; Deadline: June 18, 2020

 

NIMH

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus (NIMH)

NOT-MH-20-047; Deadline: Applications accepted on a rolling basis through April 15, 2021

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NIA, NIMH)

NOT-AG-20-022; Deadline: Applications accepted on a rolling basis through May 1, 2021

 

NIMHD

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (NIMHD, NIA, NIDA, NCI)

PA-20-172; Deadline: Letter of Intent - 9/4/2020; Application - 10/5/2020

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID- 19 Outbreak on Minority Health and Health Disparities (NIMHD)

NOT-MD-20-019; Deadline: Applications accepted on a rolling deadline from May 1, 2020 - May 1, 2021

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK (NIDDK)

NOT-DK-20-018; Deadline: June 1, 2020

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Co-morbidities, Co-infections, and Complications within NIDDK's Mission (NIDDK)

NOT-DK-20-020; Deadline: June 1, 2020

Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NIBIB)

NOT-EB-20-007; Deadline: June 5, 2020 and June 16, 2020

Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) (NCATS)

NOT-TR-20-012; Deadline: June 5, 2020 through October 16, 2020

Partnerships for Countermeasures against Select Pathogens

RFA-AI-20-028; Deadline: June 29, 2020

Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms

PAR-18-781; Deadline: September 9, 2020

 

NSF

Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)

Ecology and Evolution of Infectious Diseases (EEID)

NSF 19-592; Deadline: November 18, 2020

The multi-agency Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and social drivers that influence the transmission dynamics of infectious diseases. 

 

The Patient-Centered Outcomes Research Institute (PCORI)

The Eugene Washington PCORI Engagement Awards support projects that encourage active integration of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/comparative clinical effectiveness research (PCOR/CER) enterprise.

Supporting Engagement in and Dissemination of PCOR/CER in the Context of COVID-19; Deadline: 5/22/2020

 

Answering the call on COVID-19: just released

A total of up to $20 million will go toward funding award increases for research and other projects related to the response. It will also address appropriate changes caused by the COVID-19 emergency. For instance, some researchers may revise their plans by adding coronavirus aims to their studies or switching to virtual environments.

PCORI New Research Studies, Implementation and Engagement Projects COVID-19 commitment

 

Pfizer NEW

During this challenging time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic. We recognize the need for the rapid development of educational programs and trainings and the implementation of systemic best practices for COVID19 management. As part of our commitment, we are releasing this Request for Proposals (RFP) to provide financial support for organizations producing independent educational programs and quality improvement initiatives designed to combat this evolving crisis.

COVID-19 Competitive Grant Program; Deadline: 5/21/2020

 

Robert Wood Johnson Foundation 

As our current reality underscores, we live in a dynamic world—where unforeseen global events; new technologies; scientific discoveries; changes in our climate, economy, demographics; and more—continually shape where and how we live, learn, work and play. These changes will profoundly impact health equity in our society, from our individual health and the health of our families to the health of our communities.

Pioneering Ideas: Exploring the Future to Build a Culture of Health; Deadline: rolling

 

Russell Sage Foundation 

All Letter of Inquiry (LOI) must focus on issues related to the Foundation’s core program areas and special initiatives: Behavioral Economics; Decision-Making and Human Behavior in Context; Future of Work: Race, Ethnicity, and Immigration; Social, Political and Economic Inequality.

Funding Opportunities; Deadline: LOI due May 21, 2020; Application due August 5, 2020

 

Social Science Research Council 

In partnership with the Henry Luce Foundation, The Social Science Research Council (SSRC), as part of its Covid-19 Initiative, seeks proposals from across the social sciences and related fields that address the social, economic, cultural, psychological, and political impact of Covid-19 in the United States and globally, as well as responses to the pandemic’s wide-ranging effects.

Rapid Response Grants on COVID-19 and the Social Sciences; Deadline: June 1, 2020

 

SURF NEW

Given the urgency and overall public importance of COVID-19 research, NWO and SURF launch a COVID-19 Fast Track as part of this Compute Call. 

COVID-19 Fast Track for Computing Time; Deadline: June 30, 2020

 

Wellcome Trust in partnership with the Bill & Melinda Gates Foundation and Mastercard

The COVID-19 Therapeutics Accelerator

 

« Back to Top